The company's manufacturing base is located in the remote and temperate island of Tasmania.
The remoteness, the climate and the island condition safeguards end products from contamination with BSE (bovine spongiform encephalopathy).
[2] International Therapeutic Proteins is headquartered in the UK where administration, distribution and regulatory affairs are managed.
[3] The farms are located in Longford, where Selborne Biological Services is also operating.
This consists of an upstream (pre viral inactivation) suite for the fractionation of IgG from whole serum or plasma and a downstream (post viral inactivation) suite to conduct further processing and formulation of the Fab fragment.